Journal article
Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes
Abstract
As recently as 20 years ago there were no randomized controlled trials of potentially cardiovascular protective therapies in people with type 2 diabetes. The ongoing cardiovascular trials bring needed evidence. Both primary and subsidiary analyses have transformed diabetes from a largely eminence based specialty to one that is firmly evidence based. These studies have provided evidence supporting glucose-lowering drugs for patients with …
Authors
Gerstein HC; Shah R
Journal
Endocrinology and Metabolism Clinics of North America, Vol. 47, No. 1, pp. 97–116
Publisher
Elsevier
Publication Date
March 2018
DOI
10.1016/j.ecl.2017.10.003
ISSN
0889-8529